• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mutations flanking the carbohydrate binding site of surfactant protein d confer antiviral activity for pandemic influenza a viruses

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 4. [Epub ahead of print]
MUTATIONS FLANKING THE CARBOHYDRATE BINDING SITE OF SURFACTANT PROTEIN D CONFER ANTIVIRAL ACTIVITY FOR PANDEMIC INFLUENZA A VIRUSES.
Nikolaidis NM1, White MR, Allen K, Tripathi S, Qi L, McDonald B, Taubenberger J, Seaton BA, McCormack F, Crouch EC, Hartshorn KL.
Author information
Abstract

We recently reported that a trimeric neck and carbohydrate recognition domain (NCRD) fragment of human surfactant protein D (SP-D), a host defense lectin, with combinatorial substitutions at the 325 and 343 positions (D325A+R343V) exhibits markedly increased antiviral activity for seasonal strains of influenza A virus (IAV). The NCRD binds to glycan rich viral envelope proteins including the hemagglutinin (HA). We now show that replacement of D325 with serine to create D325S+R343V provided equal or, for one viral strain, increased neutralizing activity compared with D325A+R343V. The pandemic H1N1 strains of 1918 and 2009 have only one N-linked glycan site on the head region of the HA and are resistant to inhibition by native SP-D. In contrast, D325A+R343V and D325S+R343V inhibited Cal09 H1N1 and related strains and reduced uptake of Cal09 by epithelial cells. The activity of the double mutants was significantly greater than that of either single mutant (D325A/S or R343V). D325A+R343V and D325S+R343V also strongly inhibited HA activity, and markedly aggregated, the 1968 pandemic H3N2 strain, Aichi68. D325S+R343V significantly reduced viral loads and mortality of mice infected with Aichi68, whereas wild type SP-D NCRD did not. All known human pandemic strains have at least one glycan attachment on the HA head and our results indicate that they may be susceptible to inhibition by modified host defense lectins.
KEYWORDS:

collectin, innate immunity, mouse

PMID:
24705721
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24705721
 
Back
Top Bottom